baber/WOPTO huggingface dataset:
Patent NZ-545226-A (NZ)
Title: Sampling device for collecting a sample from a surface using a ball mechanism.
Inventor: BROOM MURRAY FREDERICK
Filed: 2004-08-20
Abstract: A method and a device for collecting a sample of material from a surface. A ball (2) within a socket (3) such that the ball is free to rotate in any direction. As the ball rolls across the surface the sample of material is collected by the ball and is transferred by the ball to a collection reservoir (not shown) via the conduit (14). An absorbent material may be placed in space (11) and a filter (10) in the outlet (9) is permeable to fluid but not absorbent material.
Patent NZ-547178-A (NZ)
Title: Method of decreasing fat deposits and body weight in mammals and birdsusing the R-isomer of Salbutamol
Inventor: ABERG GUNNAR A K
IPC: A23L33/20
Filed: 2004-11-12
Abstract: Disclosed is the use of an optically pure eutomer of salbutamol for reducing body fat and/or body weight in mammals and birds. A food composition including the eutomer is also disclosed.
Patent NZ-552851-A (NZ)
Title: Detection of a secreted polypeptide on the surface of a cell used as a marker for cellular productivity of the secreted polypeptide
Inventor: THILL GREG
IPC: C12Q1/68
Filed: 2003-05-20
Abstract: Disclosed is an in vitro method of selecting a cell producing a secreted polypeptide, the method comprising: providing a cell population, wherein the cell population comprises a cell comprising a heterologous nucleic acid encoding a secreted polypeptide; contacting the cell population with an antibody that specifically binds to the secreted polypeptide; detecting the binding of the antibody to the secreted polypeptide while transiently associated with the plasma membrane during protein secretion, wherein the detecting occurs without adding a substance to the cell that forms a matrix around the cell or immobilizes the secreted polypeptide near the cell; and selecting the cell based upon the presence or amount of the antibody bound to the secreted polypeptide transiently associated with the plasma membrane during protein secretion.
Patent NZ-555798-A (NZ)
Title: Combination food cooking oven with air impingement convection and microwave heating
Inventor: CLAESSON JAN
IPC: H05B6/64
Filed: 2005-12-14
Abstract: A combination food cooking oven includes a fan 85 disposed in a fan box 72 to circulate heated air (heated by heater 87) between the fan box and the oven chamber via a baffle plate 74, at least one impingement air generator including a jet plate 150 (and/or 152) disposed in the oven chamber that converts a portion of the circulating air to impingement air that flows in a vertical direction within the oven chamber, and a microwave generator 126 to provide microwave energy into the oven chamber via at least one wall 80, 82 of the chamber. The oven includes a controller that operates the oven in the microwave mode, an impingement mode or a combination microwave and impingement mode. The jet plate is optionally removable from the oven so that the oven can be operated in a convection or combination microwave and convection mode.
Patent NZ-560524-A (NZ)
Title: Treating or preventing rotavirus infection using conjugated linoleic acid
Inventor: MCCONNELL MICHELLE AVRIL
IPC: A23L33/00
Filed: 2007-08-09
Abstract: Provided is the use of one or more bovine milk fat compositions selected from (i) one or more phospholipid-enriched fractions of milk fat comprising about 7 to about 95% w/w lipid and about 5 to about 85% w/w phospholipid, (ii) one or more hydrolysates of a phospholipid-enriched fraction of milk fat, the fraction comprising about 7 to about 95% w/w lipid and about 5 to about 85% w/w phospholipid, and (iii) a combination of (i) and (ii), in the manufacture of a composition for treating or preventing a neuraminidase-resistant rotavirus infection in a subject.
Patent NZ-561040-A (NZ)
Title: Cat allergen fusion proteins and use thereof
Inventor: BACHMANN MARTIN
Filed: 2006-03-17
Abstract: Disclosed are compositions comprising a virus-like particle (VLP) and at least one allergen which is a feline FeI d1 protein comprised of a Fel d1 chain 1 covalently linked to a Fel d1 chain 2, wherein the VLP and allergen are covalently linked through respective attachment sites. Further disclosed are methods for producing the compositions. The compositions induce efficient immune responses, in particular antibody responses, in mammals, particularly humans. The compositions and methods of the invention are useful in the production of vaccines, in particular for the treatment and/or prevention of allergies to cat dander and other cat antigens and allergens.
Patent NZ-564084-A (NZ)
Title: Cutter assembly for extruding shaped food pieces
Inventor: HUNTER THOMAS B
IPC: A21C11/16
Filed: 2003-12-23
Abstract: A cutter assembly (1) for an extruder includes an elongated extrusion member (9) having an opened feed end (12). The opened feed end is attachable in fluid communication with a first manifold of the extruder. A filling tube (20) extends through the elongated extrusion member, which is attachable to a second manifold of the extruder. An extrusion die (11) is formed in the elongated extrusion member. The extrusion die is shaped to the general shape of a natural food piece. A cutter member (14) is reciprocally slidable on the extrusion wall (10) and has cutting surface (35) shaped to the general shape of the extrusion die for cutting extrudate to a desired length as the extrudate exits the die.
Patent NZ-566475-A (NZ)
Title: 4-phenyl-6-substituted-pyrimidine-2-carbonitrile derivatives
Inventor: RANKOVIC ZORAN
IPC: A61K31/505
Filed: 2006-09-21
Abstract: Disclosed are compounds of Formula (I), wherein the substituents are as defined in the specification; or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising the same, and the use of the compounds for the preparation of a medicament for the treatment of cathepsin K and cathepsin S related disorders including osteoporosis, atherosclerosis, inflammation and immune disorders such as rheumatoid arthritis and chronic pain.
Patent NZ-567777-A (NZ)
Title: Biocidal structural barrier (BSB)
Inventor: SANZ DANIEL
IPC: C04B111/20
Filed: 2006-11-02
Abstract: Disclosed is a concrete composition, comprising incorporated into the mass of the concrete an additive of the insecticidal biocide and/or repellent type, wherein the additive is chlorfenapyr. Also disclosed is a method of preparing said composition, in which the additive is incorporated directly into the composition or via a constituent of the composition, the use of said composition in the construction field and a method for protecting a building from harmful arthropods, comprising the step of incorporating the composition into the groundworks and/or one or more walls of the building.
Patent NZ-568024-A (NZ)
Title: Headphones with motion sensor which rewinds audio track to start of an inactive mode
Inventor: JOHNSON ELEANOR
IPC: H04M1/73
Filed: 2006-10-27
Abstract: Disclosed is an audio system with wireless headphones that detect and respond to a lack of movement. The system comprises of at least one pair of wireless headphones having an active mode and an inactive mode. The at least one pair of headphones comprising a solid-state audio player, a power source, a controller, means for connecting to a computer, and means for detecting movement of the headphones. The controller causes the headphones to be put into inactive mode when no movement is detected for a certain period of time. When movement is detected the controller the headphones to be put back into active mode, and further causes the audio player to rewind an audio track for the period of time during which no movement was detected prior to the controller causing the headphones to be put into inactive mode.
Patent NZ-570884-A (NZ)
Title: Fractionally crystallising 4-[4-(dimethyl amino)-1-(4'-fluorophenyl)-1-hydroxybutyI]-3-(hydroxymethyl)-benzonitrile and manufacturing escitalopram therefrom
Inventor: DE FAVERI CARLA
IPC: A61K31/343
Filed: 2008-08-29
Abstract: Disclosed is a method for the resolution of 4-[4-(dimethylamino)-1-(4'-fluorophenyl)-1- hydroxybutyl]-3-(hydroxymethyl)-benzonitrile as a racemic or non-racemic enantiomer mixture into its isolated enantiomers, said method comprising the step of fractionally crystallising 4-[4-(dimethylamino)-1-(4'-fluoropheny1)-1-hydroxybuty1]-3-(hydroxymethyl)-benzonitrile as a salt with the (+)-(S,S)- or (-)-(R,R)-enantiomer of O,O'-di-p-toluoyl-tartaric acid in a solvent system comprising 1-propanol as the major constituent. These solvents may be used in conjunction with a co-solvent. An achiral acid such as acetic acid, methanesulfonic acid or trifluoroacetic acid may also be present. Methods including the transformation of the isolated enantiomers into escitalopram (I) including the reaction of the (S)-enantiomer with a reactive acid derivative such as an acid chloride or acid anhydride, such as methanesulfonyl chloride or p-toluenesulfonyl chloride, in the presence of a base, e.g. pyridine or triethylamine, are also disclosed.
Patent NZ-572720-A (NZ)
Title: Zeolite amended substrate for enhancing desirable plant traits
Inventor: LEGGO PETER J
IPC: B05C1/10
Filed: 2008-11-12
Abstract: Disclosed is a method of preparing a tuff-amended plant growth substrate, comprising combining an organo-zeolitic mixture with a plant growth substrate such as animal manure andor green plant waste, in a ratio of about 1:2 to produce an amended plant growth substrate, and then adding excess zeolitic tuff, in a quantity of about 100 weight percent of that used in the organo-zeolitic mixture.
Patent NZ-585294-A (NZ)
Title: Prodrugs of piperazine and substituted piperidine antiviral agents
Inventor: UEDA YASUTSUGU
IPC: C07F9/6561
Filed: 2005-03-03
Abstract: Disclosed is a pharmaceutical composition which comprises an antiviral effective amount of the (3-(2-(4-(phenoxy)piperizinyl)-2-oxoacetyl)-4-methoxy-7-(3-methyl-1H -1,2,4-triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-1-yl)methyl dihydrogen phosphate or a pharmaceutically acceptable salt thereof, and one or more pharmaceutically acceptable carriers, excipients or diluents.
Patent NZ-585309-A (NZ)
Title: Cleaning pipe surfaces, and pipe structure to distribute particles via ejection lances as a pair that move towards and away from each other
Inventor: DALSEIDE BJORN OVE
IPC: B24C9/00
Filed: 2008-10-13
Abstract: Cleaning of extended bodies such as pipes by sealed chamber movable along body with spraying of abrasive and suction for removal A method is described for cleaning the surface of extended bodies, such as pipelines, of contaminating materials, and it is characterised by the following features: that an apparatus (20) is arranged to surround and seal around the body (10) so that a completely closed or partially closed cleaning chamber is defined between the inside of the apparatus and the outside (12) of the body (10), that a number of spraying bodies arranged in connection with the apparatus is brought to spray the surface (12) with a pressure fluid containing an abrasive agent to loosen contaminating materials, that the mixture of contaminating materials and spent abrasive agent is led away via a suction section, in a closed way for further processing, that means are used to move the apparatus (20) along the pipe surface (12), and that the abrasive agent possibly is separated and used again. An apparatus (20), a frame construction and also a pipe construction for distribution of particles are also described.
Patent NZ-591505-A (NZ)
Title: Belt-creped, variable local basis weight absorbent sheet prepared with perforated polymeric belt
Inventor: SZE DANIEL H
IPC: B31F1/07
Filed: 2010-01-28
Abstract: 591505 Disclosed is an absorbent sheet of cellulosic fibres (paper towel) with upper and lower sides, the absorbent sheet comprising: (i) fibre-enriched hollow domed regions projecting from the upper side of the sheet, the hollow domed regions having sidewalls and a local basis weight that is higher than the mean basis weight of the sheet; (ii) connecting regions forming a network interconnecting the hollow domed regions, the connecting regions having a local basis weight that is lower than the local basis weight of the hollow domed regions; and (iii) transition areas with consolidated fibrous regions that transition from the connecting regions into the hollow domed regions, by extending upwardly and inwardly from the connecting regions into the sidewalls of the hollow domed regions. Also disclosed is the method for preparing the sheet the method comprising: (a) compactively dewatering a papermaking furnish to form a nascent web having an apparently random distribution of papermaking fiber orientation; (b) applying the nascent web to a translating transfer surface that is moving at a transfer surface speed; (c) belt-creping the nascent web from the transfer surface at a consistency of from 30% to 60% utilizing a generally planar polymeric creping belt provided with perforations through the belt, the belt-creping step occurring under pressure in a belt creping nip defined between the transfer surface and the creping belt, wherein the creping belt travels at a belt speed that is slower than the transfer surface speed; and (d) drying the web.
Patent NZ-594673-A (NZ)
Title: A removable closure assembly for a container where the assembly has a spout and a removeable operating lever and closure
Inventor: SAMARTGIS JIM
IPC: B65D47/00
Filed: 2011-08-18
Abstract: A dispensing closure assembly for a container, comprises a main body member 1 adapted, in use, to be releasably affixable to the container where the main body member 1 has a dispensing means 4 associated with it , a lever or control member 10 adapted to be releasably associated with the main body member 1, and a flap or closure member 20 adapted to be releasably associated with both the main body member 1 and the lever or control member 10. The arrangement is such that movement of the lever or control member 10 allows for selective and controlled movement of the flap or closure member 20 between respective end positions into, and out of, engagement with the dispensing means 4 of the main body member 1.
Patent NZ-598466-A (NZ)
Title: Catalytic domains from lysyl oxidase and loxl2
Inventor: MCCAULEY SCOTT
IPC: C07K14/435
Filed: 2010-08-20
Abstract: 598466 Disclosed is an isolated polypeptide, comprising a catalytic domain of a human LOXL2 protein, wherein: the catalytic domain comprises an amino acid selected from the group consisting of: TAPDLVLNAEMVQQTTYLEDRPMFMLQCAMEENCLSASAAQTDPTTGYRRLLRFSSQIHNNGQSDFRPKNGRHAWIWHDCHRHYHSMEVFTHYDLLNLNGTKVAEGHKASFCLEDTECEGDIQKNYECANFGDQGITMGCWDMYRHDIDCQWVDITDVPPGDYLFQVVINPNFEVAESDYSNNIMKCRSRYDGHRIWMYNCHIGGSFSEETEKKFEHFSGLLNNQLSPQ (SEQ ID NO:3) and SEQ ID NO: 3 without the initial TA residues; and the polypeptide does not contain sequences from the human LOXL2 protein outside of its catalytic domain.
Patent NZ-599114-A (NZ)
Title: Stable anti-tnfr1 polypeptides, antibody variable domains & antagonists
Inventor: DE SILVA INUSHA
IPC: A61K39/395
Filed: 2010-10-25
Abstract: Disclosed is an anti-TNFalpha receptor type 1 immunoglobulin single variable domain comprising the amino acid sequence that is at least 95% identical to the sequence of DOM1h-574-208 (SEQ ID NO: 59), wherein the sequence is as defined in the complete specification. Also disclosed is the use of the anti-TNFalpha receptor type 1 immunoglobulin single variable domain in the manufacture of a medicament for treating and/or prophylaxis of an inflammatory condition.
Patent NZ-599971-A (NZ)
Title: Monoclonal antibodies to progastrin and their uses
Inventor: PANNEQUIN JULIE
IPC: C07K16/26
Filed: 2010-10-15
Abstract: Disclosed is an anti-hPG monoclonal antibody that specifically binds a C-terminal region of human progastrin (hPG), wherein the anti-hPG monoclonal antibody yields a statistically significant reduction in the number of live colorectal cancer cell lines after in vitro treatment of a test sample as compared to a control sample treated with a non-specific monoclonal antibody. Also disclosed is the use of the antibody in treating colorectal cancer.
Patent NZ-600635-A (NZ)
Title: 6, 11-bridged biaryl macrolides
Inventor: KIM IN JONG
IPC: C07D401/00
Filed: 2008-09-17
Abstract: 600635 Disclosed are macrolide compounds of formula (II) containing a biaryl moiety on a 6, 11-bridged macrolide system, wherein the substituents are as described within the specification.Further disclosed is a pharmaceutical composition comprising a compound of formula (I), and the use of said compound in the manufacture of a medicament for treating a bacterial infection, cystic fibrosis or an inflammatory disorder in a subject in need thereof.
Patent NZ-601525-A (NZ)
Title: Dispenser cap with selectable reservoirs
Inventor: WORTHINGTON BRIAN GLENN
IPC: B65D35/24
Filed: 2011-02-24
Abstract: 601525 A dispensing cap (1) is disclosed for mixing a primary flowable substance, such as a soap, lotion, or the like, with a small dose of a secondary flowable substance, such as a fragrance. The dispensing cap includes a plurality of reservoirs (2a-c) containing a plurality of secondary flowable substances. Each of the reservoirs is associated with a secondary piston that, when actuated, causes the secondary flowable substance to be expelled from the reservoir into a mixing chamber (4) in the cap, where it is mixed with the primary flowable substance. Upon mixing the two are dispensed together from a dispensing end of the cap. A selector ring (36) is provided to enable the user to select one of the plurality of reservoirs. The selector ring has an actuation flange that aligns with the secondary piston that is associated with the selected reservoir.
Patent NZ-602552-A (NZ)
Title: Combination of a macrocyclic inhibitor of hcv, a non-nucleoside and a nucleoside
Inventor: LENZ OLIVER
IPC: A61K31/427
Filed: 2011-04-13
Abstract: Provided is a combination comprising the macrocyclic inhibitor compound of formula I and the non-nucleoside inhibitor compound of formula III and its use in the treatment of hepatitis C virus (HCV) infections or diseases associated therewith. Additionally provided is the combination further comprising a nucleoside inhibitor, ribavirin or interferon.
Patent NZ-609745-A (NZ)
Title: Solid/fluid separation device and method for treating biomass including solid/fluid separation
Inventor: LEHOUX RICHARD ROMEO
IPC: B30B9/00
Filed: 2011-11-09
Abstract: Disclosed is a solid/fluid separating module (100) for use with a screw press for dewatering lignocellulosic biomass. The module comprises a pressurizable collection chamber (200) and at least one filter unit (300) for separating fluid from the pressurized mass and guiding the fluid into the collection chamber. The filter unit defines a core opening (128) sealed from the collection chamber for receiving the pressurized mass and includes a filter pack (321). The filter pack consists of a filter plate (120, see also figure 11), having a throughgoing filter slot (see 132, figure 11) extending away from the core opening into the filter plate for directing fluid away from the core opening, and a backer plate (160, see also figure 11). The backer plate guides fluid collected in the filter slot into the collection chamber.
Patent NZ-615299-A (NZ)
Title: Local demand side power management for electric utility networks
Inventor: JOHN TALBOT BOYS
IPC: H02J13/00
Filed: 2012-09-06
Abstract: Disclosed is an apparatus for production of a control signal for a demand side electric power supply management system. The apparatus is comprised of means to accept set point; measurement means to measure power flow into a supply network; and means to convert information from the measurement means into a control signal for transmission over the network. The frequency of the control signal is indicative of the power available to the network.
Patent NZ-616692-A (NZ)
Title: Compositions comprising antibacterial agent and tazobactam
Inventor: BHAGWAT SACHIN SUBHASH
IPC: A61P31/04
Filed: 2011-08-01
Abstract: Provided are pharmaceutical compositions comprising tazobactam and at least one antibacterial agent selected from cefepime, cefpirome, ceftobiprole, ceftaroline, cefclidine, cefluprenam, cefoselis, cefozopran, cefquinome, moxalactam, flomoxef, biapenem, panipenem, doripenem, ertapenem, meropenem, imipenem, razupenem, temocillin and CXA-101, wherein the ratio of tazobactam to antibacterial agent is from about 0.5 to about 2 grams of tazobactam per gram of antibacterial agent. The preferred antibacterial agents are cefepime and cefpirome. The compositions are useful in the treatment of bacterial infections.
Patent NZ-618191-A (NZ)
Title: Molecular diagnostic test for cancer
Inventor: PATTERSON FIONNUALA
IPC: G01N33/50
Filed: 2012-06-04
Abstract: A method of predicting a subject’s responsiveness to an anti-angiogenic therapeutic agent is diclsoed. The method comprises measuring expression levels of one or more biomarkers in a test sample of diseased tissue obtained from the subject to determine a sample expression score. The biomarkers are defined by an expression signature. The sample expression score are then compared to a threshold expression score; and the subject is classified as responsive or non-responsive, based on whether the sample expression score is above or below the threshold expression score. This method can be used to diagnose a subject as having a cancer or being susceptible to developing the cancer response to anti-angiogenic therapeutics or to determine a prognosis of a subject with cancer.
Patent NZ-705224-A (NZ)
Title: Polymer beads incorporating solid particulate material
Inventor: ZHAO WEIGUO
IPC: C08K3/10
Filed: 2013-08-28
Abstract: The present invention relates to polymer beads comprising a polymeric matrix and having a pitted surface, the polymeric matrix (i) comprising polymerised monomer residues of (a) at least one mono-ethylenically unsaturated monomer, and (b) at least one crosslinking monomer having at least two ethylenically unsaturated groups separated by at least 4 consecutive acyclic atoms, and (ii) having distributed therethrough solid particulate material and polymeric porogen.
Patent NZ-707782-A (NZ)
Title: Beverages with enhanced flavors and aromas and method of making same
Inventor: DA CRUZ MARCIO J
IPC: A23L33/15
Filed: 2009-02-19
Abstract: Disclosed is a soluble coffee beverage prepared by a method comprising: pulverizing coffee beans to form a first pulverized coffee product; grinding coffee beans to form a second ground coffee product; extracting the second ground coffee product to form an extracted coffee product and spent coffee grounds; combining a first portion of the first pulverized coffee product with the extracted coffee product to form a first coffee blend; drying the first coffee blend to form a first dried coffee blend; and combining a flavoring component, a second portion of the first pulverized coffee product and the first dried coffee blend to form the soluble coffee beverage, wherein the flavoring component comprises at least one selected from the group consisting of coffee extract, concentrated coffee, dried coffee, coffee oils, coffee aroma distillates, flavor powders, flavor oils, spices, ground or pulverized cocoa beans, and ground or pulverized vanilla beans, and wherein the soluble coffee product further comprises at least one selected from the group consisting of coffee extract, concentrated coffee, dried coffee, coffee oils, coffee aromas, distillates, flavor powders, flavor oils, spices, ground or pulverized cocoa beans, ground or pulverized vanilla beans, vitamins, antioxidants, nutraceuticals, dietary fiber, an omega-3 oil, an omega-6 oil, an omega-9 oil, a flavonoid, lycopene, selenium, a beta-carotene, resveratrol, a vegetable extract, a dry green coffee extract, a wet green coffee extract and an herbal extract.